Cite

HARVARD Citation

    Ruperto, N. et al. (n.d.). AB1182 Efficacy and safety of canakinumab, fully human anti-interleukin-1beta antibody, in systemic juvenile idiopathic arthritis. Annals of the rheumatic diseases. p. 705. [Online]. 
  
Back to record